Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s): KHRNF | KHRWF | V.KHRN.WT.H

Healthcare Cannabis

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Add To Watchlist

Bullboard (TSXV:KHRN.H)

View:

Post by Kerschbaumeron Nov 22, 2023 11:31am

Are we done?

Got this dog in my tfsa so may as well sit and wait for a miracle. Thoughts?

231

Post by zzstocks70on May 08, 2023 9:46am

Where is Chris? He got me in this way back

Thanks for the tax loss you pos

324

Post by DukeofEarlon Sep 19, 2022 1:25am

Will a raise be required?

Khiron is sailing towards profitability. Will they make it though? My fear is another raise if a sensible debt deal can't be made. Dilution at this stage would be brutal. Will the German market ...more

1169

Post by GreenTeam25on Aug 30, 2022 7:49am

An International Growth Story!

click to learn more -->

547

Post by PressReleaseon Jul 06, 2022 9:22am

New Press Release - Medical Cannabis Leader Khiron Continues Global Expansion into Spain

Khiron's Medical Clinics and Distribution Growth Throughout Europe Follows Success in Latin American MarketplaceSince establishing a Spanish subsidiary in 2019, Khiron's scientific and medical team is recognized as cannabinoid experts in SpainKhiron continues its long-standing relationship with...read article.

Post by PressReleaseon Jun 28, 2022 8:01am

New Press Release - Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin America

Khiron Serves Record Number of Patients With Khiron Products Globally in Its Medical Treatment ClinicsTORONTO, June 28, 2022 /PRNewswire/ - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) the global medical cannabis leader, continues expansion of the Khiron end-to-end...read article.

Post by PressReleaseon Jun 23, 2022 4:00pm

New Press Release - Khiron Announces Results of 2022 Annual General and Special Meeting

TORONTO, June 23, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, announces the results of its 2022 Annual General and Special Meeting of...read article.

Comment by TomConstantineon Jun 22, 2022 10:01pm

RE:ATB: Speculative Buy rating and $0.60 target price for KHRN

Good idea to go all in?

410

Discussion

Post by PressReleaseon Jun 10, 2022 12:48pm

New Press Release - KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/TORONTO, June 10, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or, the "Company") (TSXV: KHRN), (OTCQB: KHRNF...read article.

Post by PressReleaseon Jun 02, 2022 3:17pm

New Press Release - IIROC Trading Resumption - KHRN

VANCOUVER, BC, June 2, 2022 /CNW/ - Trading resumes in:Company: Khiron Life Sciences Corp.TSX-Venture Symbol: KHRNAll Issues: YesResumption (ET): 3:15 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...read article.

Post by PressReleaseon Jun 02, 2022 2:38pm

New Press Release - KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING

/NOT FOR ‎DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE ‎DISSEMINATION, DISTRIBUTION, ‎RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES./TORONTO, June 2, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) is...read article.

Post by PressReleaseon Jun 02, 2022 8:42am

New Press Release - IIROC Trading Halt - KHRN

VANCOUVER, BC, June 2, 2022 /CNW/ - The following issues have been halted by IIROC:Company: Khiron Life Sciences Corp.TSX-Venture Symbol: KHRNAll Issues: YesReason: At the Request of the Company Pending NewsHalt Time (ET): 8:35 AMIIROC can make a decision to impose a temporary suspension (halt...read article.

Post by PressReleaseon Jun 01, 2022 4:38pm

New Press Release - KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING

/NOT FOR ‎DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE ‎DISSEMINATION, DISTRIBUTION, ‎RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/TORONTO, June 1, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) is...read article.

Post by PressReleaseon May 31, 2022 9:28am

New Press Release - Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint

The acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmaciesThe acquisition will provide Khiron with an EU GMP-certified European manufacturing and distribution hub for various pharmaceutical...read article.

Post by PressReleaseon May 31, 2022 8:48am

New Press Release - PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khiron

Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce that it has entered into an agreement on May 31, 2022 with Khiron Life Sciences Corp. (TSXV: KHRN) ("Khiron") to sell all of the outstanding...read article.

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities